BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 965092)

  • 1. Molecular forms of neurotoxins in proteolytic Clostridium botulinum type B cultures.
    Dasgupta BR; Sugiyama H
    Infect Immun; 1976 Sep; 14(3):680-6. PubMed ID: 965092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.
    Dekleva ML; DasGupta BR
    Biochem Biophys Res Commun; 1989 Jul; 162(2):767-72. PubMed ID: 2667520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of intracellular type A botulinum neurotoxin.
    Krysinski EP; Sugiyama H
    Appl Environ Microbiol; 1981 Mar; 41(3):675-8. PubMed ID: 7013709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin types A, B & E: pH induced difference spectra.
    Datta A; DasGupta BR
    Mol Cell Biochem; 1988 Jun; 81(2):187-94. PubMed ID: 3050452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and amino acid composition of type A botulinum neurotoxin.
    DasGupta BR; Sathyamoorthy V
    Toxicon; 1984; 22(3):415-24. PubMed ID: 6382680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial amino acid sequences of botulinum neurotoxins types B and E.
    Schmidt JJ; Sathyamoorthy V; DasGupta BR
    Arch Biochem Biophys; 1985 May; 238(2):544-8. PubMed ID: 3888113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of botulinum toxins in the absence of nicking.
    Ohishi I; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):402-7. PubMed ID: 19360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent structure of botulinum neurotoxin type B; location of sulfhydryl groups and disulfide bridge and identification of C-termini of light and heavy chains.
    Antharavally BS; DasGupta BR
    J Protein Chem; 1998 Jul; 17(5):417-28. PubMed ID: 9717738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a protease in natural activation of Clostridium botulinum neurotoxin.
    Das Gupta BR; Sugiyama H
    Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E.
    Sathyamoorthy V; DasGupta BR
    J Biol Chem; 1985 Sep; 260(19):10461-6. PubMed ID: 4030755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative molecular topography of botulinum neurotoxins from Clostridium butyricum and Clostridium botulinum type E.
    Singh BR; Giménez JA; DasGupta BR
    Biochim Biophys Acta; 1991 Mar; 1077(1):119-26. PubMed ID: 1901221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is formation of visible channels in a phospholipid bilayer by botulinum neurotoxin type B sensitive to its disulfide?
    Flicker PF; Robinson JP; DasGupta BR
    J Struct Biol; 1999 Dec; 128(3):297-304. PubMed ID: 10633069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity.
    Shone CC; Hambleton P; Melling J
    Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nicking the C-terminal region of the Clostridium botulinum serotype D neurotoxin heavy chain on its toxicity and molecular properties.
    Suzuki T; Kouguchi H; Watanabe T; Hasegawa K; Yoneyama T; Niwa K; Nishikawa A; Lee JC; Oguma K; Ohyama T
    Protein J; 2007 Apr; 26(3):173-81. PubMed ID: 17200883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin type B (strain 657): partial sequence and similarity with tetanus toxin.
    Dasgupta BR; Datta A
    Biochimie; 1988 Jun; 70(6):811-7. PubMed ID: 3139097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated light chains of botulinum neurotoxins inhibit exocytosis. Studies in digitonin-permeabilized chromaffin cells.
    Bittner MA; DasGupta BR; Holz RW
    J Biol Chem; 1989 Jun; 264(18):10354-60. PubMed ID: 2732226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular dichroic and fluorescence spectroscopic study of the conformation of botulinum neurotoxin types A and E.
    Datta A; DasGupta BR
    Mol Cell Biochem; 1988 Feb; 79(2):153-9. PubMed ID: 3398838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.